Patent · US Active

Modified KZ144 endolysin sequence

US10184120B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

LYSANDO AG · LI

Inventors

Stefan Miller · Regensburg, DE
Reinhard Sterner · Regensburg, DE
Heike Stüer · Pentling, DE

Key dates

Filing date	Nov 14, 2014
Grant date	Jan 22, 2019
Priority date	—
Expiry date	Oct 9, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to polypeptides comprising an amino acid sequence exhibiting at least about 90% sequence identity with the sequence of SEQ ID NO: 1. Said polypeptides preferably degrade the peptidoglycan of Gram-negative bacteria, in particular of Pseudomonas and/or Campylobacter bacteria. In addition, the present invention relates to nucleic acids encoding such polypeptides, vectors comprising such nucleic acids, and corresponding host cells. Finally, the present invention relates to compositions comprising such polypeptides, nucleic acids, vectors, and/or host cells according to the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.